Pulmonology Month in Review: May 2024
This review of May 2024 covered several notable topics in the pulmonary health field, including research into vaping, lung abnormalities, and treatment of COPD.
Source: hcplive.com
Biologic License Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biologic License Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biologic License Application Today - Breaking & Trending Today
FDA Extends Dupilumab COPD Decision to September 2024
The FDA moved the target date for their decision on the dupilumab application by 3 months, citing a need for more efficacy data from its pivotal phase 3 trials.
Source: hcplive.com
Hansa Biopharma AB: Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
LUND, Sweden, May 21, 2024 /PRNewswire/ --. Hansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant
Source: finanznachrichten.de
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
07.05.2024 - Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year guidance ...
Source: wallstreet-online.de
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1...
Source: marketscreener.com